Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., & Ning, Y.| Journal of Psychopharmacology | 27 September 2018
Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy
Hendricks, P. S. | International Review of Psychiatry | 27 September 2018
Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models
Volgin, A. D., Yakovlev, O. A., Demin, K. A., Alekseeva, P. A., Kyzar, E. J., Collins, C., ... & Kalueff, A. V. | ACS chemical neuroscience | 25 September 2018
Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy
Walsh, Z., & Thiessen, M. S. | International Review of Psychiatry | 25 September 2018
Psychedelics and music: neuroscience and therapeutic implications
Barrett, F. S., Preller, K. H., & Kaelen, M. | International Review of Psychiatry | 21 September 2018
Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
Olson, D. E. | Journal of experimental neuroscience | 19 September 2018
Dimensions of consciousness and the psychedelic state
Bayne, T., & Carter, O. | Neuroscience of consciousness | 19 September 2018
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
Ionescu, D. F., Bentley, K. H., Eikermann, M., Taylor, N., Johnson-Akeju, O., Swee, M. B., ... & Alpert, J. E. | Journal of Affective Disorders | 17 September 2018
Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model
Peto, K., Nemeth, N., Mester, A., Magyar, Z., Ghanem, S., Somogyi, V., ... & Nemes, B. | Clinical hemorheology and microcirculation | 14 September 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. | Psychopharmacology | 8 September 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. | Psychopharmacology | 8 September 2018
Serotonin, psychedelics and psychiatry
Carhart‐Harris, R. L. | World Psychiatry | 7 September 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness
Thomas, R. K., Baker, G., Lind, J., & Dursun, S. | Journal of psychopharmacology | 5 September 2018
Psychedelics, Meditation, and Self-Consciousness
Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F. M., & Berkovich-Ohana, A. | Frontiers in psychology | 4 September 2018
A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus
Lima, R. V., Moulin, T., Lintzmaier, L. P., & Leão, R. N. | Frontiers in molecular neuroscience | 04 September 2018
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
De, D. G., Enns, J. P., Nuñez, N. A., Posa, L., & Gobbi, G. | Progress in brain research | 31 August 2018
LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice.
Alper, K., Dong, B., Shah, R., Sershen, H., & Vinod, K. Y. | Frontiers in pharmacology | 31 August 2018
Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic
Horák, M., Hasíková, L., & Verter, N. | Journal of psychoactive drugs | 30 August 2018
It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish
Eduardo-da-Silva, P., Lobao-Soares, B., Amarilha, H., Pinheiro-da-Silva, J., Silva, P. F., & Luchiari, A. C. | Frontiers in behavioral neuroscience | 27 August 2018
The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training
Nielson, E. M., & Guss, J. | Journal of Psychedelic Studies | 22 August 2018
Legitimate Medicine in the Age of Consumerism
Lamkin, M. | 21 August 2018
DMT Models the Near-Death Experience
Timmermann, C., Roseman, L., Williams, L., Erritzoe, D., Martial, C., Cassol, H., ... & Carhart-Harris, R. | Frontiers in psychology | 15 August 2018
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
dos Santos, R. G., Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. | Expert review of clinical pharmacology | 13 August 2018
Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress
Ross, S. | International Review of Psychiatry | 13 August 2018
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
Uthaug, M. V., van Oorsouw, K., Kuypers, K. P. C., van Boxtel, M., Broers, N. J., Mason, N. L., & Ramaekers, J. G. | Psychopharmacology | 13 August 2018